Equity Overview
Price & Market Data
Price: $0.348
Daily Change: -$0.0109 / 3.13%
Range: $0.323 - $0.359
Market Cap: $8,529,660
Volume: 521,961
Performance Metrics
1 Week: -40.66%
1 Month: -86.95%
3 Months: -92.61%
6 Months: -94.25%
1 Year: -98.81%
YTD: -94.03%
Details
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.